Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Keen, GB

Dominic John Keen, London GB

Patent application numberDescriptionPublished
20110191856RECEIVING INPUT DATA - A method of securing the inputting of sensitive information by a user, the method comprising: generating a mapping that associates each symbol of a plurality of symbols with a respective location at which to display that symbol on a display; displaying the plurality of symbols to the user, each symbol being displayed at the associated location on the display according to the generated mapping; the user providing a sequence of selections, each selection being a selection of a respective one of the locations; and converting the sequence of selections into a corresponding sequence of input symbols representing the input from user, each input symbol being the symbol associated with the respective selected location in the sequence of selections according to the generated mapping.08-04-2011

Ian Keen, Yateley GB

Patent application numberDescriptionPublished
20100285672VARIABLE CONFIGURATION APPARATUS - A variable configuration apparatus has components or sub-systems. At least some components (11-11-2010

Ian J. Keen, Yately GB

Patent application numberDescriptionPublished
20090312011COMMUNICATIONS DEVICES COMPRISING NEAR FIELD RF COMMUNICATORS - A communications device has a near field RF communicator (12-17-2009

Michael J. Keen, Stevenage GB

Patent application numberDescriptionPublished
20080279852Methods of treatment with glycosylated antibodies - The present invention relates to methods of treating a human patient suffering from rheumatoid arthritis, comprising: 11-13-2008

Philip Keen, Bristol GB

Patent application numberDescriptionPublished
20100161174Landing Load Monitor for Aircraft Landing Gear - A landing gear monitor for aircraft landing gear including a plurality of pairs of wheels on a bogie, in which the main strut oil pressure serves to indicate landing load and is monitored in relation to, respectively, the two-wheel mode and the four-wheel mode, the two-wheel mode being the condition when a first of the plurality of pairs of wheels on the bogie contacts the ground and the four-wheel mode being the condition of a first and a second of the plurality of pairs of wheels on the bogie being in full contact with the ground.06-24-2010

Simon Keen, Cambridge GB

Patent application numberDescriptionPublished
20090041797MODIFIED TOXINS - The present application relates to compositions of modified toxins exhibiting reduced immunogenicity and reduced binding to vascular endothelium or vascular endothelial cells, thereby reducing the incidence of Vascular Leak Syndrome. Also provided are polypeptide toxophores from a modified diphtheria toxin, where modifications are in at least one amino acid residue of at least one T-cell epitope. Another aspect relates to a polypeptide toxophore from a modified diphtheria toxin, where modifications are in at least one amino acid residue of at least one T-cell epitope and at least one amino acid residue of at least one VLS motif of an unmodified native diphtheria toxin. Another aspect relates to a fusion protein which comprises a modified diphtheria toxin and a non-diphtheria toxin fragment that is a cell binding portion. Another aspect relates to the use of a modified diphtheria toxin for the treatment of a malignant disease or a non-malignant disease.02-12-2009
20090221500MODIFIED TOXINS - The present application relates to compositions of modified toxins exhibiting reduced immunogenicity and reduced binding to vascular endothelium or vascular endothelial cells, thereby reducing the incidence of Vascular Leak Syndrome. Also provided are polypeptide toxophores from a modified diphtheria toxin, where modifications are in at least one amino acid residue of at least one T-cell epitope. Another aspect relates to a polypeptide toxophore from a modified diphtheria toxin, where modifications are in at least one amino acid residue of at least one T-cell epitope and at least one amino acid residue of at least one VLS motif of an unmodified native diphtheria toxin. Another aspect relates to a fusion protein which comprises a modified diphtheria toxin and a non-diphtheria toxin fragment that is a cell binding portion. Another aspect relates to the use of a modified diphtheria toxin for the treatment of a malignant disease or a non-malignant disease.09-03-2009

Simon William Keen, Cambridgeshire GB

Patent application numberDescriptionPublished
20090196880Cancer treatment using humanized antibodies that bind to EphB4 - In certain embodiments, this application provides humanized antibodies that bind to the EphB4 protein as well as uses of the antibodies for therapeutic purposes.08-06-2009

Stephen Keen, Warwickshire GB

Patent application numberDescriptionPublished
20090175301FIBRE LASER SYSTEM - A fibre laser system is disclosed comprising an optical fibre, a part of which is doped with a rare earth to form an optical gain medium; at least one laser diode; means for applying pump radiation from the laser diode to the optical gain medium and for generating a laser beam and delivery fibre means for delivering a laser beam to a workpiece, wherein the fibre laser is provided with at least one means for protecting one or more components from damage caused by errant radiation. Several different means of protection are disclosed.07-09-2009
20100124393SYSTEM FOR DELIVERING THE OUTPUT FROM AN OPTICAL FIBRE - A termination for an optical fibre is disclosed, including an end cap optically connected to a delivery end of the fibre and tapering its towards its proximal end so as to expand the signal beam output by the fibre, a capillary having a bore mounted so that the end cap and an end portion of the delivery fibre are mounted within the bore, the capillary having an end which is angled so as to reflect undesired radiation within the capillary away from the fibre, and a cladding mode stripper arranged upstream of the delivery end.05-20-2010